TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Nec Oncoimmunity AS
Closing information (x1000 DKK)
Closing information | 2023/03 | 2022/03 | 2021/03 |
Turnover |
2,119
|
1,846
|
5,447 |
Financial expenses |
1,580
|
633
|
692 |
Earnings before taxes |
-23,932
|
-18,732
|
-15,823 |
Total assets |
48,033
|
102,302
|
28,210 |
Current assets |
42,939
|
94,958
|
28,023 |
Current liabilities |
8,145
|
27,257
|
12,397 |
Equity capital |
39,888
|
75,046
|
15,812 |
- share capital |
231
|
220
|
211 |
Employees (average) | 18 | 16 |
Financial ratios
Fiscal year | 2023/03 | 2022/03 | 2021/03 |
Solvency |
83.0%
|
73.4%
|
56.1% |
Turnover per employee | 118 | 340 | |
Profit as a percentage of turnover |
-1129.4%
|
-1014.7%
|
-290.5% |
Return on assets (ROA) |
-46.5%
|
-17.7%
|
-53.6% |
Current ratio |
527.2%
|
348.4%
|
226.0% |
Return on equity (ROE) |
-60.0%
|
-25.0%
|
-100.1% |
Change turnover |
550
|
-3,822
|
-6,192 |
Change turnover % |
35%
|
-67%
|
-53% |
Chg. No. of employees | 1 | ||
Chg. No. of employees % | 7% |
Total value of public sale
Fiscal year | 2023/03 | 2022/03 | 2021/03 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.